|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1995-12-19
|
|
pubmed:abstractText |
Transitional cell carcinoma (TCC) of the ovary is reportedly more sensitive to first-line chemotherapy and has a better prognosis than the more common serous carcinoma. The purpose of this study was to determine the responsiveness of refractory ovarian TCC to salvage chemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0090-8258
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
59
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
211-5
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:7590475-Adult,
pubmed-meshheading:7590475-Aged,
pubmed-meshheading:7590475-Antineoplastic Agents,
pubmed-meshheading:7590475-Carcinoma, Transitional Cell,
pubmed-meshheading:7590475-Female,
pubmed-meshheading:7590475-Humans,
pubmed-meshheading:7590475-Middle Aged,
pubmed-meshheading:7590475-Ovarian Neoplasms,
pubmed-meshheading:7590475-Retrospective Studies,
pubmed-meshheading:7590475-Salvage Therapy
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Salvage chemotherapy for refractory transitional cell carcinoma of the ovary (TCC).
|
|
pubmed:affiliation |
Department of Gynecologic Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
|
|
pubmed:publicationType |
Journal Article
|
